Benefits Think We’re in the middle of a specialty medication storm. Now what?
Zack Pace is senior vice president, benefits consulting at CBIZ, Inc.
Zack Pace is senior vice president, benefits consulting at CBIZ, Inc.
For reprint and licensing requests for this article, click here.
With health benefit costs expected to rise 8.2% in 2027, employers are looking for ways to control spending without simply shifting more costs to workers.
Collaboration between employers, brokers and third-party administrators will be essential to developing customized, cost-effective and employee-friendly solutions.
As costs to treat serious conditions surge, employers must plan how to absorb budget-altering expenses ahead of time.
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
Rising use of the weight-loss drug is fueling the fastest health plan cost growth in a decade and a half, forcing employers to rethink coverage strategies and cost management.